The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes—a meta-analysis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2015) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,533
Dong, Y., Hao, L., Shi, Z., Wang, G., Zhang, Z., & Han, C. (2013) · Urologia Internationalis · doi:10.1159/000351405 · Cited by 4,540
Marshall, D., Johnell, O., & Wedel, H. (1996) · BMJ · doi:10.1136/bmj.312.7041.1254 · Cited by 3,709
Body mass index as a predictor of fracture risk: A meta-analysis
De Laet, C., Kanis, J. A., Odén, A., Johanson, H., Johnell, O., Delmas, P., Eisman, J. A., Kroger, H., Fujiwara, S., Garnero, P., et al. (2005) · Osteoporosis International · doi:10.1007/s00198-005-1863-y · Cited by 1,622
Older Women with Diabetes Have an Increased Risk of Fracture: A Prospective Study
Schwartz, A. V. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.1.32 · Cited by 789
Type 1 and Type 2 Diabetes and Incident Hip Fractures in Postmenopausal Women
Nicodemus, K. K., & Folsom, A. R. (2001) · Diabetes Care · doi:10.2337/diacare.24.7.1192 · Cited by 568
Vestergaard, P., Rejnmark, L., & Mosekilde, L. (2005) · Diabetologia · doi:10.1007/s00125-005-1786-3 · Cited by 557
Self-citationBone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study.
de Liefde, I. I., van der Klift, M., de Laet, C. E. D. H., van Daele, P. L. A., Hofman, A., & Pols, H. A. P. (2005) · Osteoporosis International · doi:10.1007/s00198-005-1909-1 · Cited by 555
Bone mineral density in patients with type 1 and type 2 diabetes.
Tuominen, J. T., Impivaara, O., Puukka, P., & Rönnemaa, T. (1999) · Diabetes Care · doi:10.2337/diacare.22.7.1196 · Cited by 392
Cited by
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
“Type 1 diabetes is associated with osteoporosis, but in type 2 diabetes an increased risk of hip fracture is seen despite higher bone mineral density (BMD) (488).”
BackgroundInfluentialStandards of medical care in diabetes—2013
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc13-s011 · Cited by 4,369
Standards of Medical Care in Diabetes—2012
(2012) · Diabetes Care · doi:10.2337/dc12-s011 · Cited by 2,240
Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction
Achari, A., & Jain, S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061321 · Cited by 1,158
Mechanisms of diabetes mellitus-induced bone fragility
On behalf of the IOF Bone and Diabetes Working Group, Napoli, N., Chandran, M., Pierroz, D. D., Abrahamsen, B., Schwartz, A. V., & Ferrari, S. L. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.153 · Cited by 1,107
Growth Hormone, Insulin-Like Growth Factors, and the Skeleton
Giustina, A., Mazziotti, G., & Canalis, E. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0036 · Cited by 914
Saito, M., & Marumo, K. (2010) · Osteoporosis International · doi:10.1007/s00198-009-1066-z · Cited by 906
Association of BMD and FRAX Score With Risk of Fracture in Older Adults With Type 2 Diabetes
Schwartz, A. V. (2011) · JAMA · doi:10.1001/jama.2011.715 · Cited by 717
Molecular Mechanisms Controlling Bone Formation during Fracture Healing and Distraction Osteogenesis
AI-Aql, Z. S., Alagl, A. S., Graves, D. T., Gerstenfeld, L. C., & Einhorn, T. A. (2008) · Journal of Dental Research · doi:10.1177/154405910808700215 · Cited by 691
Xiao, P.-L., Cui, A.-Y., Hsu, C.-J., Peng, R., Jiang, N., Xu, X.-H., Ma, Y.-G., Liu, D., & Lu, H.-D. (2022) · Osteoporosis International · doi:10.1007/s00198-022-06454-3 · Cited by 573
Japanese clinical practice guideline for diabetes 2019
Araki, E., Goto, A., Kondo, T., Noda, M., Noto, H., Origasa, H., Osawa, H., Taguchi, A., Tanizawa, Y., Tobe, K., et al. (2020) · Diabetology International · doi:10.1007/s13340-020-00439-5 · Cited by 545
Understanding the Bone in Cancer Metastasis
Fornetti, J., Welm, A. L., & Stewart, S. A. (2018) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3618 · Cited by 526
Diabetes and Its Effect on Bone and Fracture Healing
Jiao, H., Xiao, E., & Graves, D. T. (2015) · Current Osteoporosis Reports · doi:10.1007/s11914-015-0286-8 · Cited by 522
In Vivo Assessment of Bone Quality in Postmenopausal Women With Type 2 Diabetes
Farr, J. N., Drake, M. T., Amin, S., Melton, L. J., McCready, L. K., & Khosla, S. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2106 · Cited by 499
Burghardt, A. J., Issever, A. S., Schwartz, A. V., Davis, K. A., Masharani, U., Majumdar, S., & Link, T. M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0226 · Cited by 460
Effects of canagliflozin on fracture risk in patients with type 2 diabetes mellitus
Watts, N. B., Bilezikian, J. P., Usiskin, K., Edwards, R., Desai, M., Law, G., & Meininger, G. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3167 · Cited by 454
Bone fragility in diabetes: novel concepts and clinical implications
Hofbauer, L. C., Busse, B., Eastell, R., Ferrari, S., Frost, M., Müller, R., Burden, A. M., Rivadeneira, F., Napoli, N., & Rauner, M. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00347-8 · Cited by 440
Increased cortical porosity in type 2 diabetic postmenopausal women with fragility fractures
Patsch, J. M., Burghardt, A. J., Yap, S. P., Baum, T., Schwartz, A. V., Joseph, G. B., & Link, T. M. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1763 · Cited by 436
Bone Quality: The Determinants of Bone Strength and Fragility
Fonseca, H., Moreira-Gonçalves, D., Coriolano, H.-J. A., & Duarte, J. A. (2014) · Sports Medicine · doi:10.1007/s40279-013-0100-7 · Cited by 429
Marrow Fat and Bone—New Perspectives
Fazeli, P. K., Horowitz, M. C., MacDougald, O. A., Scheller, E. L., Rodeheffer, M. S., Rosen, C. J., & Klibanski, A. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3634 · Cited by 416
Fracture Risk in Type 2 Diabetes: Update of a Population-Based Study
Melton, L. J., Leibson, C. L., Achenbach, S. J., Therneau, T. M., & Khosla, S. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080323 · Cited by 416
Ma, L., Oei, L., Jiang, L., Estrada, K., Chen, H., Wang, Z., Yu, Q., Zillikens, M. C., Gao, X., & Rivadeneira, F. (2012) · European Journal of Epidemiology · doi:10.1007/s10654-012-9674-x · Cited by 412
Diagnosis and management of bone fragility in diabetes: an emerging challenge
Ferrari, S. L., Abrahamsen, B., Napoli, N., Akesson, K., Chandran, M., Eastell, R., El-Hajj Fuleihan, G., Josse, R., Kendler, D. L., Kraenzlin, M., et al. (2018) · Osteoporosis International · doi:10.1007/s00198-018-4650-2 · Cited by 398
Bodai, B. I., & Tuso, P. (2015) · The Permanente Journal · doi:10.7812/tpp/14-241 · Cited by 397
Ma, H., Wang, X., Zhang, W., Li, H., Zhao, W., Sun, J., & Yang, M. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/9067610 · Cited by 392
Bone Turnover Markers: Basic Biology to Clinical Applications
Schini, M., Vilaca, T., Gossiel, F., Salam, S., & Eastell, R. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnac031 · Cited by 387
Bone, sweet bone—osteoporotic fractures in diabetes mellitus
Hamann, C., Kirschner, S., Günther, K.-P., & Hofbauer, L. C. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.233 · Cited by 380
Systemic Complications of Acromegaly and the Impact of the Current Treatment Landscape: An Update
Gadelha, M. R., Kasuki, L., Lim, D. S. T., & Fleseriu, M. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00115 · Cited by 363
Leslie, W. D., Rubin, M. R., Schwartz, A. V., & Kanis, J. A. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1759 · Cited by 352
Japanese Clinical Practice Guideline for Diabetes 2019
Araki, E., Goto, A., Kondo, T., Noda, M., Noto, H., Origasa, H., Osawa, H., Taguchi, A., Tanizawa, Y., Tobe, K., et al. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13306 · Cited by 341
Ebeling, P. R., Nguyen, H. H., Aleksova, J., Vincent, A. J., Wong, P., & Milat, F. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab028 · Cited by 338
Patsch, J. M., Li, X., Baum, T., Yap, S. P., Karampinos, D. C., Schwartz, A. V., & Link, T. M. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1950 · Cited by 332
MANAGEMENT OF ENDOCRINE DISEASE: Secondary osteoporosis: pathophysiology and management
Mirza, F., & Canalis, E. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0118 · Cited by 331
Yamamoto, M., Yamaguchi, T., Yamauchi, M., Kaji, H., & Sugimoto, T. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.081207 · Cited by 327
Hygum, K., Starup-Linde, J., Harsløf, T., Vestergaard, P., & Langdahl, B. L. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0652 · Cited by 320
Self-citationPentosidine and Increased Fracture Risk in Older Adults with Type 2 Diabetes
Schwartz, A. V., Garnero, P., Hillier, T. A., Sellmeyer, D. E., Strotmeyer, E. S., Feingold, K. R., Resnick, H. E., Tylavsky, F. A., Black, D. M., Cummings, S. R., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2498 · Cited by 317
Diabetes mellitus related bone metabolism and periodontal disease
Wu, Y.-Y., Xiao, E., & Graves, D. T. (2015) · International Journal of Oral Science · doi:10.1038/ijos.2015.2 · Cited by 310
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s004 · Cited by 285
Vestergaard, P., Rejnmark, L., & Mosekilde, L. (2009) · Calcified Tissue International · doi:10.1007/s00223-008-9195-5 · Cited by 283
Self-citationWeber, D. R., Haynes, K., Leonard, M. B., Willi, S. M., & Denburg, M. R. (2015) · Diabetes Care · doi:10.2337/dc15-0783 · Cited by 274
Fracture risk in diabetic elderly men: the MrOS study
Napoli, N., Strotmeyer, E. S., Ensrud, K. E., Sellmeyer, D. E., Bauer, D. C., Hoffman, A. R., Dam, T.-T. L., Barrett-Connor, E., Palermo, L., Orwoll, E. S., et al. (2014) · Diabetologia · doi:10.1007/s00125-014-3289-6 · Cited by 272
Guidelines for the diagnosis, prevention and management of osteoporosis
Rossini, M., Adami, S., Bertoldo, F., Diacinti, D., Gatti, D., Giannini, S., Giusti, A., Malavolta, N., Minisola, S., Osella, G., et al. (2016) · Reumatismo · doi:10.4081/reumatismo.2016.870 · Cited by 272
Circulating Sclerostin Levels and Bone Turnover in Type 1 and Type 2 Diabetes
Gennari, L., Merlotti, D., Valenti, R., Ceccarelli, E., Ruvio, M., Pietrini, M. G., Capodarca, C., Franci, M. B., Campagna, M. S., Calabrò, A., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2958 · Cited by 272
Dipeptidyl Peptidase-4 Inhibitors and Bone Fractures
Monami, M., Dicembrini, I., Antenore, A., & Mannucci, E. (2011) · Diabetes Care · doi:10.2337/dc11-1099 · Cited by 268
The osteocyte as a signaling cell
Delgado-Calle, J., & Bellido, T. (2022) · Physiological Reviews · doi:10.1152/physrev.00043.2020 · Cited by 261
Update on the pathogenesis and treatment of skeletal fragility in type 2 diabetes mellitus
Khosla, S., Samakkarnthai, P., Monroe, D. G., & Farr, J. N. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00555-5 · Cited by 260
Nilsson, A. G., Sundh, D., Johansson, L., Nilsson, M., Mellström, D., Rudäng, R., Zoulakis, M., Wallander, M., Darelid, A., & Lorentzon, M. (2017) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3057 · Cited by 217
Advanced glycation end products, diabetes, and bone strength
Yamamoto, M., & Sugimoto, T. (2016) · Current Osteoporosis Reports · doi:10.1007/s11914-016-0332-1 · Cited by 215
“Indeed, several studies of non-diabetic subjects revealed that increased AGEs crosslinking was associated with reduced post-yield properties and toughness [31, 32, 38–41]. Curr Osteoporos Rep (2016) 14:320–326 321”
BackgroundMiao, R., Fang, X., Zhang, Y., Wei, J., Zhang, Y., & Tian, J. (2023) · Cell Death & Disease · doi:10.1038/s41419-023-05708-0 · Cited by 192
Fracture Healing in the Setting of Endocrine Diseases, Aging, and Cellular Senescence
Saul, D., & Khosla, S. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac008 · Cited by 185
Shanbhogue, V. V., Hansen, S., Frost, M., Jørgensen, N. R., Hermann, A. P., Henriksen, J. E., & Brixen, K. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2573 · Cited by 183
“Indeed, the heterogeneity in the representation of patients with MVD in the studies included in the aforementionedmeta-analysis((4)) could also be partly responsible for thediscrepancyobserved in theexpectedandobserved fracture risk.”
BackgroundResultInfluentialPrevalence of Vertebral Fractures in Men with Acromegaly
Mazziotti, G., Bianchi, A., Bonadonna, S., Cimino, V., Patelli, I., Fusco, A., Pontecorvi, A., De Marinis, L., & Giustina, A. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0791 · Cited by 169
Quantitative imaging techniques for the assessment of osteoporosis and sarcopenia
Guerri, S., Mercatelli, D., Aparisi Gómez, M. P., Napoli, A., Battista, G., Guglielmi, G., & Bazzocchi, A. (2018) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims.2018.01.05 · Cited by 169
How safe is the use of thiazolidinediones in clinical practice?
Rizos, C., Elisaf, M., Mikhailidis, D., & Liberopoulos, E. (2009) · Expert Opinion on Drug Safety · doi:10.1517/14740330802597821 · Cited by 161
3. Foundations of Care and Comprehensive Medical Evaluation
American Diabetes Association (2016) · Diabetes Care · doi:10.2337/dc16-s006 · Cited by 159
Bone disease in diabetes: another manifestation of microvascular disease?
Shanbhogue, V. V., Hansen, S., Frost, M., Brixen, K., & Hermann, A. P. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30134-1 · Cited by 158
Madeira, M., Neto, L. V., de Paula Paranhos Neto, F., Barbosa Lima, I. C., Carvalho de Mendonça, L. M., Gadelha, M. R., & Fleiuss de Farias, M. L. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4073 · Cited by 114
Mazziotti, G., Porcelli, T., Patelli, I., Vescovi, P. P., & Giustina, A. (2010) · Bone · doi:10.1016/j.bone.2009.10.031 · Cited by 113
Morelli, V., Masserini, B., Salcuni, A. S., Eller‐Vainicher, C., Savoca, C., Viti, R., Coletti, F., Guglielmi, G., Battista, C., Iorio, L., et al. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03794.x · Cited by 107
Vertebral fractures in males with prolactinoma
Mazziotti, G., Porcelli, T., Mormando, M., De Menis, E., Bianchi, A., Mejia, C., Mancini, T., De Marinis, L., & Giustina, A. (2011) · Endocrine · doi:10.1007/s12020-011-9462-5 · Cited by 109
Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors: A Clinician’s Guide
Simes, B. C., & MacGregor, G. G. (2019) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s212003 · Cited by 103
Okazaki, K., Yamaguchi, T., Tanaka, K.-I., Notsu, M., Ogawa, N., Yano, S., & Sugimoto, T. (2012) · Calcified Tissue International · doi:10.1007/s00223-012-9641-2 · Cited by 98
Mazziotti, G., Mancini, T., Mormando, M., De Menis, E., Bianchi, A., Doga, M., Porcelli, T., Vescovi, P. P., De Marinis, L., & Giustina, A. (2011) · Pituitary · doi:10.1007/s11102-011-0293-4 · Cited by 98
Advanced Glycation Endproducts and Bone Material Properties in Type 1 Diabetic Mice
Rubin, M. R., Paschalis, E. P., Poundarik, A., Sroga, G. E., McMahon, D. J., Gamsjaeger, S., Klaushofer, K., & Vashishth, D. (2016) · PLOS ONE · doi:10.1371/journal.pone.0154700 · Cited by 90
“Surprisingly, fracture risk is not fully accounted for in either type 1 (T1D) or type 2 (T2D) diabetes by measurement of bone mineral density (BMD) by dual energy X-ray absorptiometry [1].”
InfluentialPFAS and Potential Adverse Effects on Bone and Adipose Tissue through Interactions with PPARγ
Kirk, A. B., Michelsen-Correa, S., Rosen, C., Martin, C. F., & Blumberg, B. (2021) · Endocrinology · doi:10.1210/endocr/bqab194 · Cited by 90
Effects of TZD use and discontinuation on fracture rates in ACCORD bone study
Schwartz, A. V., Chen, H., Ambrosius, W. T., Sood, A., Josse, R. G., Bonds, D. E., Schnall, A. M., Vittinghoff, E., Bauer, D. C., Banerji, M. A., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1215 · Cited by 85
Driessen, J. H. M., Henry, R. M. A., van Onzenoort, H. A. W., Lalmohamed, A., Burden, A. M., Prieto-Alhambra, D., Neef, C., Leufkens, H. G. M., & de Vries, F. (2015) · Calcified Tissue International · doi:10.1007/s00223-015-9993-5 · Cited by 79
Contributors to impaired bone health in type 2 diabetes
Sheu, A., Greenfield, J. R., White, C. P., & Center, J. R. (2023) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2022.11.003 · Cited by 69
Mazziotti, G., Porcelli, T., Bianchi, A., Cimino, V, Patelli, I., Mejia, C., Fusco, A., Giampietro, A., De Marinis, L., & Giustina, A. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0125 · Cited by 68
Obesity is associated with early hip fracture risk in postmenopausal women: a 25-year follow-up
Rikkonen, T., Sund, R., Sirola, J., Honkanen, R., Poole, K. E. S., & Kröger, H. (2021) · Osteoporosis International · doi:10.1007/s00198-020-05665-w · Cited by 52
Grey, A., Bolland, M., Fenwick, S., Horne, A., Gamble, G., Drury, P. L., & Reid, I. R. (2014) · European Journal of Endocrinology · doi:10.1530/eje-13-0793 · Cited by 43
Osima, M., Kral, R., Borgen, T. T., Høgestøl, I. K., Joakimsen, R. M., Eriksen, E. F., & Bjørnerem, Å. (2017) · Bone · doi:10.1016/j.bone.2017.01.037 · Cited by 39
The effects of type 1 and type 2 diabetes mellitus on bone health in chronic kidney disease
Aleksova, J., Ebeling, P., & Elder, G. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-01083-8 · Cited by 20
Tramontana, F., Napoli, N., Litwack-Harrison, S., Bauer, D. C., Orwoll, E. S., Cauley, J. A., Strotmeyer, E. S., & Schwartz, A. V. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae045 · Cited by 18
Dalla Grana, E., Rigo, F., Lanzafame, M., Lattuada, E., Suardi, S., Mottes, M., Valenti, M. T., & Dalle Carbonare, L. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00302 · Cited by 17
Büchi, A. E., Feller, M., Netzer, S., Blum, M. R., Gonzalez Rodriguez, E., Collet, T.-H., Del Giovane, C., van Heemst, D., Quinn, T., Kearney, P. M., et al. (2022) · Bone · doi:10.1016/j.bone.2022.116404 · Cited by 14
Metadata
- Authors
- Vestergaard, P.
- Venue
- Osteoporosis International
- Published
- 2006-10-27
- Volume
- 18
- Issue
- 4
- Pages
- 427-444
- ISSN
- 0937-941X (ISSN-L)
- 1433-2965
- OpenAlex
- W2141260918
- Cited by
- 1,808
- References
- 83
- FWCI
- 4.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.